Correlation Between Evolus and Intra Cellular

Can any of the company-specific risk be diversified away by investing in both Evolus and Intra Cellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evolus and Intra Cellular into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Evolus Inc and Intra Cellular Therapies, you can compare the effects of market volatilities on Evolus and Intra Cellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evolus with a short position of Intra Cellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evolus and Intra Cellular.

Diversification Opportunities for Evolus and Intra Cellular

-0.33

Correlation Coefficient

Evolus  Intra Cellular

Very good diversification

The 3 months correlation between Evolus and Intra is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and Intra Cellular Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intra Cellular Therapies and Evolus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evolus Inc are associated (or correlated) with Intra Cellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intra Cellular Therapies has no effect on the direction of Evolus i.e., Evolus and Intra Cellular go up and down completely randomly.

Pair Corralation between Evolus and Intra Cellular

If you would invest  13,187  in Intra Cellular Therapies on May 19, 2025 and sell it today you would earn a total of  0.00  from holding Intra Cellular Therapies or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.59%
Values	Daily Returns

Evolus Inc  vs.  Intra Cellular Therapies

Evolus Inc

Risk-Adjusted Performance

Weakest

Over the last 90 days Evolus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in September 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Intra Cellular Therapies

Risk-Adjusted Performance

Weakest

Over the last 90 days Intra Cellular Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, Intra Cellular is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Evolus and Intra Cellular

The main advantage of trading using opposite Evolus and Intra Cellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evolus position performs unexpectedly, Intra Cellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intra Cellular will offset losses from the drop in Intra Cellular's long position.

The idea behind Evolus Inc and Intra Cellular Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.